LOADING
Comparing Eli Lilly and Company (LLY) and Thermo Fisher Scientific (TMO), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | LLY | TMO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | -- | $195.9B |
| P/E Ratio | -- | 29.0 |
| Forward P/E | -- | 21.2 |
| PEG Ratio | -- | 1.74 |
| EPS | -- | $18.18 |
| Revenue Growth (YoY) | -- | 6.2% |
| Profit Margin | -- | 15.1% |
| Return on Equity | -- | 13.5% |
| Dividend Yield | -- | 0.34% |
| Beta | -- | 0.87 |
| 52-Week High | -- | $642.71 |
| 52-Week Low | -- | $401.89 |
| Volume | -- | -- |